Multiple cardiovascular and inflammatory targets

The entry "Multiple cardiovascular and inflammatory targets" is a non-specific descriptor used to categorize a wide range of distinct biological molecules rather than a single, identifiable therapeutic target. It encompasses various proteins, enzymes, and receptors that play critical roles in the pathophysiology of heart disease and systemic inflammation, such as the Angiotensin-Converting Enzyme (ACE), HMG-CoA reductase, and Tumor Necrosis Factor (TNF). Because it represents a heterogeneous group of targets, it lacks a unified molecular classification, biological function, or mechanism of action. This terminology is frequently used in pharmacological literature to describe the pleiotropic effects of drugs like statins or colchicine, which modulate multiple pathways to reduce cardiovascular risk and inflammatory markers (Source: PubMed, PMID: 30243146; StatPearls, "Statins"). Consequently, this entry is considered incorrect for structured data purposes as it does not map to a unique molecular entity. In drug discovery, identifying specific targets within this broad category is essential for understanding efficacy and safety profiles. Analysts should look for specific protein names or gene symbols to accurately characterize drug-target interactions.

Not applicable